Recombinant Human EphB2 Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 5189-B2
Key Product Details
Source
NS0
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Binding Activity
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human EphB2 protein
Human EphB2 (Val19-Leu543) Accession # P29323 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Val19
Predicted Molecular Mass
84.7 kDa (monomer)
SDS-PAGE
103-108 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human EphB2 Fc Chimera is coated at 2 μg/mL, Recombinant Human Ephrin-B2 Fc Chimera (Catalog # 7397-EB) binds with an apparent Kd <0.1 nM.
When Recombinant Human EphB2 Fc Chimera is coated at 2 μg/mL, Recombinant Human Ephrin-B2 Fc Chimera (Catalog # 7397-EB) binds with an apparent Kd <0.1 nM.
Formulation, Preparation and Storage
5189-B2
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 200 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: EphB2
(6-10). EphB2 interaction with Ephrin-A5 promotes axonal growth cone collapse, while its interaction with Ephrin-B ligands is required for inner ear, renal, urorectal, and vascular development (6, 11-15). Signaling in Ephrin expressing cells through EphB2-Ephrin complex requires proteolytic cleavage of EphB2 that releases its extracellular domain (16). Following the shedding of the extracellular domain of EphB2, the cytoplasmic domain of EphB2 is released from the plasma membrane by the presenilin-dependent gamma-secretase activity to initiate a signaling cascade in the EphB2 expressing cells (16). Aberrant EphB2 expression and activity are implicated in the progression of several cancers (17).
References
- Pasquale, E.B. (2008) Cell 133:38.
- Merlos-Suarez, A. and E. Batlle (2008) Curr. Opin. Cell Biol. 20:194.
- Fox, G.M. et al. (1995) Oncogene 10:897.
- Tang, X.X. et al. (1998) Oncogene, 17:521.
-
Lauterbach, J. and R. Klein (2006) J. Neurosci. 26:11575.
- Cowan C.A. et al. (2000) Neuron 26:417.
- Bouvier, D. et al. (2008) J. Neurochem. 106:682.
- Cramer, K.S. et al. (2006) Dev. Biol. 295:76.
- Katakowski, M. et al. (2005) Neurosci. Lett. 385:204.
- Henderson, J.T. et al. (2001) Neuron 32:1041.
- Himanen, J.-P. et al. (2004) Nat. Neurosci. 7:501.
- Dravis, C. et al. (2007) Hear. Res. 223:93.
- Dravis, C. et al. (2004) Dev. Biol. 271:272.
- Ogawa, K. et al. (2006) J. Cell Sci. 119:559.
- Salvucci, O. et al. (2006) Blood 108:2914.
- Litterst, C. et al. (2007) J. Biol. Chem. 282:16155.
- Castano, J. et al. (2008) Histol. Histopathol. 23:1011.
Long Name
Eph Receptor B2
Alternate Names
Cek5, Drt, Erk, Hek5, Nuk, Qek2, Sek3, Tyro5
Gene Symbol
EPHB2
UniProt
Additional EphB2 Products
Product Documents for Recombinant Human EphB2 Fc Chimera Protein, CF
Product Specific Notices for Recombinant Human EphB2 Fc Chimera Protein, CF
For research use only
Loading...
Loading...
Loading...